SEC Form 4 · accession 0001144204-17-064156
Neurotrope, Inc. · NTRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Susanne Wilke
Other
Period of report
Dec 14, 2017
Accepted (ET)
Dec 18, 2017 · 5:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001513856
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $7.55 | Dec 14, 2017 | A | 10,000 | A | Dec 14, 2017 | Dec 14, 2027 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1Such option grant was granted under the Issuer's 2017 Equity Incentive Plan pursuant to a separation agreement dated December 14, 2017, by and between the Issuer and the Reporting Person.
- F2The stock options shall be fully vested as of the date of grant.